A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

Vendrell, J.A., Robertson, K.E., Ravel, P. et al. (10 more authors) (2008) A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Breast Cancer Research, 10 (5). R88 .

Abstract

Metadata

Authors/Creators:
  • Vendrell, J.A.
  • Robertson, K.E.
  • Ravel, P.
  • Bray, S.E.
  • Bajard, A.
  • Purdie, C.A.
  • Nguyen, C.
  • Hadad, S.M.
  • Bieche, I.
  • Chabaud, S.
  • Bachelot, T.
  • Thompson, A.M.
  • Cohen, P.A.
Copyright, Publisher and Additional Information: © 2008 Vendrell et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biological Markers; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Estrogen Receptor Modulators; Estrogens; Female; Gene Expression Profiling; Humans; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Oligonucleotide Array Sequence Analysis; Proportional Hazards Models; RNA, Messenger; RNA, Neoplasm; Receptors, Estrogen; Salvage Therapy; Tamoxifen; Treatment Failure
Dates:
  • Published: 2008
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 02 Mar 2015 15:48
Last Modified: 02 Mar 2015 15:48
Published Version: http://dx.doi.org/10.1186/bcr2158
Status: Published
Publisher: BioMed Central
Identification Number: https://doi.org/10.1186/bcr2158
Related URLs:

Export

Statistics